BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32188314)

  • 1. Percutaneous nephrostomy placement in pregnant patients: a retrospective single center experience.
    Epelboym Y; Tivnan P; Desai K; O'Horo S
    J Matern Fetal Neonatal Med; 2022 Mar; 35(5):970-974. PubMed ID: 32188314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A ten-year, single institution experience with percutaneous nephrostomy during pregnancy.
    Lindquester WS; Novelli PM; Amesur NB; Warhadpande S; Orons PD
    Clin Imaging; 2021 Apr; 72():42-46. PubMed ID: 33212305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from Literature: Nephrostomy Versus Double J Ureteral Catheterization in Patients with Obstructive Urolithiasis-Which Method Is Superior?
    Weltings S; Schout BMA; Roshani H; Kamphuis GM; Pelger RCM
    J Endourol; 2019 Oct; 33(10):777-786. PubMed ID: 31250680
    [No Abstract]   [Full Text] [Related]  

  • 4. Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome.
    Alago W; Sofocleous CT; Covey AM; Thornton RH; Donat SM; Brody LA; Getrajdman GI; Brown KT
    AJR Am J Roentgenol; 2008 Nov; 191(5):1536-9. PubMed ID: 18941097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous nephrostomy placement in infants and young children.
    Hwang JY; Shin JH; Lee YJ; Yoon HM; Cho YA; Kim KS
    Diagn Interv Imaging; 2018 Mar; 99(3):157-162. PubMed ID: 28774588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Outcomes of Double-Layered Polytetrafluoroethylene Membrane-Covered Self-Expandable Segmental Metallic Stents (Uventa) in Patients with Chronic Ureteral Obstructions: Is It Really Safe?
    Kim M; Hong B; Park HK
    J Endourol; 2016 Dec; 30(12):1339-1346. PubMed ID: 27736158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
    Song Y; Fei X; Song Y
    Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ureteral stent placement without postprocedural nephrostomy tube: experience in 41 patients.
    Patel U; Abubacker MZ
    Radiology; 2004 Feb; 230(2):435-42. PubMed ID: 14688404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival time and period of catheterization in patients treated with percutaneous nephrostomy for urinary obstruction due to malignancy.
    Radecka E; Magnusson M; Magnusson A
    Acta Radiol; 2006 Apr; 47(3):328-31. PubMed ID: 16613316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Nephrostomy in Neonates and Young Infants.
    Cyphers E; Gaballah M; Acord M; Worede F; Srinivasan A; Vatsky SE; Escobar F; Krishnamurthy G; Cahill AM
    J Vasc Interv Radiol; 2023 Oct; 34(10):1815-1821. PubMed ID: 37336489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandem Ureteral Stents for Malignant Ureteral Obstruction.
    Haifler M; Shvero A; Zilberman D; Ramon J; Winkler H; Margel D; Kleinmann N
    J Endourol; 2020 Feb; 34(2):222-226. PubMed ID: 31724450
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of percutaneous nephrostomy (PCN) in malignant ureteral obstruction.
    Jalbani MH; Deenari RA; Dholia KR; Oad AK; Arbani IA
    J Pak Med Assoc; 2010 Apr; 60(4):280-3. PubMed ID: 20419970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergent ureteric stent vs percutaneous nephrostomy for obstructive urolithiasis with sepsis: patterns of use and outcomes from a 15-year experience.
    Goldsmith ZG; Oredein-McCoy O; Gerber L; Bañez LL; Sopko DR; Miller MJ; Preminger GM; Lipkin ME
    BJU Int; 2013 Jul; 112(2):E122-8. PubMed ID: 23795789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous nephrostomy versus retrograde ureteral stent for acute upper urinary tract obstruction with urosepsis.
    Xu ZH; Yang YH; Zhou S; Lv JL
    J Infect Chemother; 2021 Feb; 27(2):323-328. PubMed ID: 33309627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and timing of inadvertent nephrostomy catheter displacement in patients with ureteral obstruction
.
    Niwa N; Matsumoto K; Kikuchi E; Yazawa S; Takeda T; Morita S; Kosaka T; Shinoda K; Mizuno R; Shinojima T; Asanuma H; Oya M
    Clin Nephrol; 2018 Aug; 90(2):112-116. PubMed ID: 29578400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ureteric stent versus percutaneous nephrostomy for acute ureteral obstruction - clinical outcome and quality of life: a bi-center prospective study.
    Shoshany O; Erlich T; Golan S; Kleinmann N; Baniel J; Rosenzweig B; Eisner A; Mor Y; Ramon J; Winkler H; Lifshitz D
    BMC Urol; 2019 Aug; 19(1):79. PubMed ID: 31455309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous CT-guided nephrostomy: a safe and quick alternative method in management of obstructive and nonobstructive uropathy.
    Thanos L; Mylona S; Stroumpouli E; Kalioras V; Pomoni M; Batakis N
    J Endourol; 2006 Jul; 20(7):486-90. PubMed ID: 16859461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications.
    Hausegger KA; Portugaller HR
    Eur Radiol; 2006 Sep; 16(9):2016-30. PubMed ID: 16547709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
    Tan S; Tao Z; Bian X; Zhao Y; Wang N; Chen X; Wu B
    Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():99-103. PubMed ID: 31484100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.